Inventor
VAN VLASSELAER PETER
US27 patents
⚠️ This page may combine multiple inventors who share the name “VAN VLASSELAER PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TRUE NORTH THERAPEUTICS INC
8 patentsUS8945562B2Feb 3, 2015
Anti-complement C1s antibodies
TRUE NORTH THERAPEUTICS INC24 citations96
US9562092B2Feb 7, 2017
Methods of inhibiting complement C4 activation with anti-complement C1s antibodies
TRUE NORTH THERAPEUTICS INC10 citations92
US9512233B2Dec 6, 2016
Anti-complement C1s antibodies and methods of inhibiting complement C1s activity
TRUE NORTH THERAPEUTICS INC12 citations92
US9206259B2Dec 8, 2015
Methods of inhibiting complement C4 activation with anti-complement C1S antibodies
TRUE NORTH THERAPEUTICS INC15 citations92
US9074003B2Jul 7, 2015
Methods of inhibiting activation of complement component C4 with anti-C1s antibodies
TRUE NORTH THERAPEUTICS INC15 citations92
US9074004B2Jul 7, 2015
Methods of inhibiting activation of complement component C4 with anti-C1s antibodies
TRUE NORTH THERAPEUTICS INC15 citations92
US8877197B2Nov 4, 2014
Anti-complement C1s
TRUE NORTH THERAPEUTICS INC22 citations92
US9562106B2Feb 7, 2017
Anti-complement C1s antibodies and methods of inhibiting complement C1s activity
TRUE NORTH THERAPEUTICS INC8 citations84
ACTIVATED CELL THERAPY INC
5 patentsUS5840502ANov 24, 1998
Methods for enriching specific cell-types by density gradient centrifugation
ACTIVATED CELL THERAPY INC384 citations99
US5646004AJul 8, 1997
Methods for enriching fetal cells from maternal body fluids
ACTIVATED CELL THERAPY INC162 citations99
US5577513ANov 26, 1996
Centrifugation syringe, system and method
ACTIVATED CELL THERAPY INC214 citations99
US5474687ADec 12, 1995
Methods for enriching CD34+ human hematopoietic progenitor cells
ACTIVATED CELL THERAPY INC157 citations99
US5648223AJul 15, 1997
Methods for enriching breast tumor cells
ACTIVATED CELL THERAPY INC103 citations98
BIOVERATIV USA INC
4 patentsUS10457745B2Oct 29, 2019
Anti-complement C1s antibodies
BIOVERATIV USA INC6 citations83
US10450382B2Oct 22, 2019
Anti-complement C1s antibodies
BIOVERATIV USA INC8 citations83
US12215169B2Feb 4, 2025
Anti-complement C1s antibodies and uses thereof
BIOVERATIV USA INC1 citations74
US12240917B2Mar 4, 2025
Anti-complement C1s antibodies and uses thereof
BIOVERATIV USA INC0 citations62
GILEAD BIOLOGICS INC
3 patentsUS9176139B2Nov 3, 2015
LOX and LOXL2 inhibitors and uses thereof
GILEAD BIOLOGICS INC16 citations91
US8658167B2Feb 25, 2014
Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
GILEAD BIOLOGICS INC19 citations91
US10494443B2Dec 3, 2019
LOX and LOXL2 inhibitors and uses thereof
GILEAD BIOLOGICS INC0 citations50